Literature DB >> 18544649

The p110beta isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110gamma.

Julie Guillermet-Guibert1, Katja Bjorklof, Ashreena Salpekar, Cristiano Gonella, Faruk Ramadani, Antonio Bilancio, Stephen Meek, Andrew J H Smith, Klaus Okkenhaug, Bart Vanhaesebroeck.   

Abstract

The p110 isoforms of phosphoinositide 3-kinase (PI3K) are acutely regulated by extracellular stimuli. The class IA PI3K catalytic subunits (p110alpha, p110beta, and p110delta) occur in complex with a Src homology 2 (SH2) domain-containing p85 regulatory subunit, which has been shown to link p110alpha and p110delta to Tyr kinase signaling pathways. The p84/p101 regulatory subunits of the p110gamma class IB PI3K lack SH2 domains and instead couple p110gamma to G protein-coupled receptors (GPCRs). Here, we show, using small-molecule inhibitors with selectivity for p110beta and cells derived from a p110beta-deficient mouse line, that p110beta is not a major effector of Tyr kinase signaling but couples to GPCRs. In macrophages, both p110beta and p110gamma contributed to Akt activation induced by the GPCR agonist complement 5a, but not by the Tyr kinase ligand colony-stimulating factor-1. In fibroblasts, which express p110beta but not p110gamma, p110beta mediated Akt activation by the GPCR ligands stromal cell-derived factor, sphingosine-1-phosphate, and lysophosphatidic acid but not by the Tyr kinase ligands PDGF, insulin, and insulin-like growth factor 1. Introduction of p110gamma in these cells reduced the contribution of p110beta to GPCR signaling. Taken together, these data show that p110beta and p110gamma can couple redundantly to the same GPCR agonists. p110beta, which shows a much broader tissue distribution than the leukocyte-restricted p110gamma, could thus provide a conduit for GPCR-linked PI3K signaling in the many cell types where p110gamma expression is low or absent.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18544649      PMCID: PMC2448830          DOI: 10.1073/pnas.0707761105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Early embryonic lethality in mice deficient in the p110beta catalytic subunit of PI 3-kinase.

Authors:  Lei Bi; Ichiro Okabe; David J Bernard; Robert L Nussbaum
Journal:  Mamm Genome       Date:  2002-03       Impact factor: 2.957

2.  Kinetic analysis of platelet-derived growth factor receptor/phosphoinositide 3-kinase/Akt signaling in fibroblasts.

Authors:  Chang Shin Park; Ian C Schneider; Jason M Haugh
Journal:  J Biol Chem       Date:  2003-07-18       Impact factor: 5.157

3.  Not so strange bedfellows: G-protein-coupled receptors and Src family kinases.

Authors:  Deirdre K Luttrell; Louis M Luttrell
Journal:  Oncogene       Date:  2004-10-18       Impact factor: 9.867

4.  A function for phosphoinositide 3-kinase beta lipid products in coupling beta gamma to Ras activation in response to lysophosphatidic acid.

Authors:  Armelle Yart; Serge Roche; Reinhard Wetzker; Muriel Laffargue; Nicholas Tonks; Patrick Mayeux; Hugues Chap; Patrick Raynal
Journal:  J Biol Chem       Date:  2002-03-26       Impact factor: 5.157

5.  Purification and characterization of Gbetagamma-responsive phosphoinositide 3-kinases from pig platelet cytosol.

Authors:  X Tang; C P Downes
Journal:  J Biol Chem       Date:  1997-05-30       Impact factor: 5.157

6.  Rapid generation of inducible mouse mutants.

Authors:  Jost Seibler; Branko Zevnik; Birgit Küter-Luks; Susanne Andreas; Heidrun Kern; Thomas Hennek; Anja Rode; Cornelia Heimann; Nicole Faust; Gunther Kauselmann; Michael Schoor; Rudolf Jaenisch; Klaus Rajewsky; Ralf Kühn; Frieder Schwenk
Journal:  Nucleic Acids Res       Date:  2003-02-15       Impact factor: 16.971

7.  Class I phosphoinositide 3-kinase p110beta is required for apoptotic cell and Fcgamma receptor-mediated phagocytosis by macrophages.

Authors:  Yann Leverrier; Klaus Okkenhaug; Carol Sawyer; Antonio Bilancio; Bart Vanhaesebroeck; Anne J Ridley
Journal:  J Biol Chem       Date:  2003-07-16       Impact factor: 5.157

8.  Cloning, expression, purification, and characterization of the human Class Ia phosphoinositide 3-kinase isoforms.

Authors:  Timothy I Meier; James A Cook; James E Thomas; Jeffrey A Radding; Candice Horn; Trupti Lingaraj; Michele C Smith
Journal:  Protein Expr Purif       Date:  2004-06       Impact factor: 1.650

9.  PI3Kgamma modulates the cardiac response to chronic pressure overload by distinct kinase-dependent and -independent effects.

Authors:  Enrico Patrucco; Antonella Notte; Laura Barberis; Giulio Selvetella; Angelo Maffei; Mara Brancaccio; Stefano Marengo; Giovanni Russo; Ornella Azzolino; Sergei D Rybalkin; Lorenzo Silengo; Fiorella Altruda; Reinhard Wetzker; Matthias P Wymann; Giuseppe Lembo; Emilio Hirsch
Journal:  Cell       Date:  2004-08-06       Impact factor: 41.582

10.  Requirement for PI 3-kinase gamma in macrophage migration to MCP-1 and CSF-1.

Authors:  Gareth E Jones; Elena Prigmore; Ronan Calvez; Catherine Hogan; Graham A Dunn; Emilio Hirsch; Matthias P Wymann; Anne J Ridley
Journal:  Exp Cell Res       Date:  2003-10-15       Impact factor: 3.905

View more
  168 in total

1.  Different Isoforms of the Neuronal Guidance Molecule Slit2 Directly Cause Chemoattraction or Chemorepulsion of Human Neutrophils.

Authors:  Darrell Pilling; Luis E Chinea; Kristen M Consalvo; Richard H Gomer
Journal:  J Immunol       Date:  2018-12-03       Impact factor: 5.422

2.  A constitutively activated form of the p110beta isoform of PI3-kinase induces prostatic intraepithelial neoplasia in mice.

Authors:  Sang Hyun Lee; George Poulogiannis; Saumyadipta Pyne; Shidong Jia; Lihua Zou; Sabina Signoretti; Massimo Loda; Lewis Clayton Cantley; Thomas M Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

Review 3.  Specific PI3K isoform modulation in heart failure: lessons from transgenic mice.

Authors:  Alessandra Ghigo; Fulvio Morello; Alessia Perino; Federico Damilano; Emilio Hirsch
Journal:  Curr Heart Fail Rep       Date:  2011-09

4.  Addition of N-terminal peptide sequences activates the oncogenic and signaling potentials of the catalytic subunit p110α of phosphoinositide-3-kinase.

Authors:  Minghao Sun; Jonathan R Hart; Petra Hillmann; Marco Gymnopoulos; Peter K Vogt
Journal:  Cell Cycle       Date:  2011-11-01       Impact factor: 4.534

5.  Gastric inhibitory peptide controls adipose insulin sensitivity via activation of cAMP-response element-binding protein and p110β isoform of phosphatidylinositol 3-kinase.

Authors:  Sameer Mohammad; Lavoisier S Ramos; Jochen Buck; Lonny R Levin; Francesco Rubino; Timothy E McGraw
Journal:  J Biol Chem       Date:  2011-10-25       Impact factor: 5.157

Review 6.  The emerging mechanisms of isoform-specific PI3K signalling.

Authors:  Bart Vanhaesebroeck; Julie Guillermet-Guibert; Mariona Graupera; Benoit Bilanges
Journal:  Nat Rev Mol Cell Biol       Date:  2010-04-09       Impact factor: 94.444

7.  Activity of any class IA PI3K isoform can sustain cell proliferation and survival.

Authors:  Lazaros C Foukas; Inma M Berenjeno; Alexander Gray; Asim Khwaja; Bart Vanhaesebroeck
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

8.  Tyrosine phosphorylation of the Gα-interacting protein GIV promotes activation of phosphoinositide 3-kinase during cell migration.

Authors:  Changsheng Lin; Jason Ear; Yelena Pavlova; Yash Mittal; Irina Kufareva; Majid Ghassemian; Ruben Abagyan; Mikel Garcia-Marcos; Pradipta Ghosh
Journal:  Sci Signal       Date:  2011-09-27       Impact factor: 8.192

9.  Biased binding of class IA phosphatidyl inositol 3-kinase subunits to inducible costimulator (CD278).

Authors:  Yenny Y Acosta; Maria Paz Zafra; Gloria Ojeda; Ilaria Seren Bernardone; Umberto Dianzani; Pilar Portolés; Jose M Rojo
Journal:  Cell Mol Life Sci       Date:  2010-12-28       Impact factor: 9.261

10.  Ras is an indispensable coregulator of the class IB phosphoinositide 3-kinase p87/p110gamma.

Authors:  Barbara Kurig; Aliaksei Shymanets; Thomas Bohnacker; Carsten Brock; Mohammad Reza Ahmadian; Michael Schaefer; Antje Gohla; Christian Harteneck; Matthias P Wymann; Elisabeth Jeanclos; Bernd Nürnberg
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.